Incyte Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones08-07

DJ Incyte Corp. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Incyte Corp. $(INCY)$ slid 1.19% to $118.38 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.18% to 7,709.96 and Dow Jones Industrial Average falling 0.85% to 53,885.10.

This was the stock's second consecutive day of losses.

Incyte Corp. closed 10.72% below its 52-week high of $132.60, which the company reached on July 28th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ fell 5.51% to $216.12, Bio-Techne Corp. (TECH) fell 0.14% to $71.90, and BioMarin Pharmaceutical Inc. $(BMRN)$ rose 2.59% to $61.46.

Trading volume (2.4 M) eclipsed its 50-day average volume of 2.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 6, 2026.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2657566563?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-07 05:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2657566563","market":"sh","top_or_hot":-1,"title":"Incyte Corp. Stock Outperforms Competitors Despite Losses on the Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Incyte Corp. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Incyte Corp. <a href=\"https://laohu8.com/S/INCY\">$(INCY)$</a> slid 1.19% to $118.38 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&amp;P 500 Index  falling 0.18% to 7,709.96 and Dow Jones Industrial Average  falling 0.85% to 53,885.10. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Incyte Corp. closed 10.72% below its 52-week high of $132.60, which the company reached on July 28th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Alnylam Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/ALNY\">$(ALNY)$</a> fell 5.51% to $216.12, <a href=\"https://laohu8.com/S/TECH\">Bio-Techne</a> Corp. (TECH) fell 0.14% to $71.90, and BioMarin Pharmaceutical Inc. <a href=\"https://laohu8.com/S/BMRN\">$(BMRN)$</a> rose 2.59% to $61.46. \n</p>\n<p>\n     Trading volume (2.4 M) eclipsed its 50-day average volume of 2.0 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled August 6, 2026. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Incyte Corp. Stock Outperforms Competitors Despite Losses on the Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIncyte Corp. Stock Outperforms Competitors Despite Losses on the Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-08-07 05:04</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Incyte Corp. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Incyte Corp. <a href=\"https://laohu8.com/S/INCY\">$(INCY)$</a> slid 1.19% to $118.38 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&amp;P 500 Index  falling 0.18% to 7,709.96 and Dow Jones Industrial Average  falling 0.85% to 53,885.10. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Incyte Corp. closed 10.72% below its 52-week high of $132.60, which the company reached on July 28th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Alnylam Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/ALNY\">$(ALNY)$</a> fell 5.51% to $216.12, <a href=\"https://laohu8.com/S/TECH\">Bio-Techne</a> Corp. (TECH) fell 0.14% to $71.90, and BioMarin Pharmaceutical Inc. <a href=\"https://laohu8.com/S/BMRN\">$(BMRN)$</a> rose 2.59% to $61.46. \n</p>\n<p>\n     Trading volume (2.4 M) eclipsed its 50-day average volume of 2.0 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled August 6, 2026. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INCY","symbol_name":"因塞特医疗","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2657566563","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2657566563","pubTimestamp":1786050240,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"DJ Incyte Corp. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Incyte Corp.  slid 1.19% to $118.38 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.18% to 7,709.96 and Dow Jones Industrial Average  falling 0.85% to 53,885.10.This was the stock's second consecutive day of losses.Incyte Corp. closed 10.72% below its 52-week high of $132.60, which the company reached on July 28th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Alnylam Pharmaceuticals Inc.  fell 5.51% to $216.12, Bio-Techne Corp.  fell 0.14% to $71.90, and BioMarin Pharmaceutical Inc.  rose 2.59% to $61.46.Trading volume  eclipsed its 50-day average volume of 2.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 6, 2026.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"INCY":"因塞特医疗"},"translate_title":"尽管当天亏损，Incyte Corp. 股票仍跑赢竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INCY":1.5},"content_text":"DJ Incyte Corp. Stock Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Incyte Corp. $(INCY)$ slid 1.19% to $118.38 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.18% to 7,709.96 and Dow Jones Industrial Average  falling 0.85% to 53,885.10. \n\n\n     This was the stock's second consecutive day of losses. \n\n\n     Incyte Corp. closed 10.72% below its 52-week high of $132.60, which the company reached on July 28th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ fell 5.51% to $216.12, Bio-Techne Corp. (TECH) fell 0.14% to $71.90, and BioMarin Pharmaceutical Inc. $(BMRN)$ rose 2.59% to $61.46. \n\n\n     Trading volume (2.4 M) eclipsed its 50-day average volume of 2.0 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled August 6, 2026.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2657566563","isCrawlerRequest":true}